Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515995 · ClinicalTrials.gov registry record · Phase 4
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01515995: Completed Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
NCT01515995 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01515995, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as a vehicle for albuterol in children with moderate to severe asthma exacerbation.
Primary Outcome
Change in forced expiratory volume in one second (FEV1) as measured by bedside spirometry before and after study intervention.
Interventions
- DRUG Nebulized magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-10 |
| Phase | Phase 4 |
What the finished NCT01515995 record still lists
NCT01515995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Nebulized magnesium sulfate is the first listed.
NCT01515995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01515995 about?
NCT01515995 is a clinical study titled "Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation". The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as a vehicle for albuterol in children with moderate to severe asthma exacerbation.
What is the current status of trial NCT01515995?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01515995?
The interventions under investigation include: Nebulized magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT01515995?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01515995's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia